EMD Millipore will be presenting the latest innovations for enhancing drug bioavailability, decreasing solvents waste and exposure, and expansion/harmonization of chemicals and reagents at American Association of Pharmaceutical Scientists (AAPS) from October 14th to 18th 2012 in Chicago, Illinois.

BioavailabilityEMD Millipore offers a broad portfolio of products and technologies for enhancing drug bioavailability. Supported by a legacy of expertise with pharmaceutical raw materials, the portfolio includes solutions to address all major aspects of bioavailability including solubility, PK/PD modifiers, targeting, and optimized formulation. Bioavailability solutions from EMD Millipore offer a unique blend of broad experience, deep application know-how, and cGMP production capabilities to support customers from API development to registration of the final dosage form.

Expanded Chemical and Reagents PortfolioPreviously only available outside North America, this portfolio of more than 14,000 products will enable customers in R&D and analytical labs in North America to access the same products of exacting quality, using the same product codes, as colleagues in other countries. Global standardization of EMD Millipore's product offerings translates into a harmonized solution, in addition to providing North American customers a greater choice including a wider range of pack sizes. The products offer superior specifications and innovative, environmentally friendly packaging for less waste and greater safety.

EMD Millipore's EMD ReCyclerTM program This innovative solution significantly reduces the waste typically associated with solvent usage and disposal, decreasing the carbon footprint. In addition, the service reduces researchers' exposure to solvents associated with use of small, disposable containers increasing the safety of the lab and those who work in it.

EMD Millipore technical experts will be presenting the following posters: